96439 ⎘
Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof sharing nitrogen; Heterocyclic radicals containing only nitrogen atoms as ring hetero atom Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups -
MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF
#2CD73 INHIBITORS
#3ADENOSINE ANALOGS FOR THE TREATMENT OF DISEASE
#4SARS-COV-2 NSP14 METHYLTRANSFERASE INHIBITORS
#5CD73 INHIBITORS
#6Nucleoside Analogues for the Treatment of Parasitic Infections
#7INHIBITORS OF ADENOSINE 5'-NUCLEOTIDASE
#8NITROGEN-CONTAINING BRIDGED HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF
#9PHENOXAZINE DERIVATIVE AND DRUG DELIVERY SYSTEM FORMULATION USING SAME
#10Glycosylation method involving trivalent iodine reagent
#11COMPOSITIONS FOR TREATMENT OF INFLAMMATION
#12CD73 INHIBITORS
#13METHODS OF PREPARING 1'-CYANO NUCLEOSIDES
#14MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF
#15Inhibitors of adenosine 5′-nucleotidase
#16NUCLEOSIDE ANALOG AND USE THEREOF
#17HETEROCYCLIC INHIBITORS OF CD73 FOR TREATMENT OF DISEASE
#18HETEROCYCLIC INHIBITORS OF CD73 FOR TREATMENT OF DISEASE
#19ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE THEREOF
#20CD73 INHIBITORS
#21METHOD FOR PRODUCING IMIDAZOPYRIDINE DERIVATIVE
#22METTL3 MODULATORS
#23Crystalline forms of a CD73 inhibitor and uses thereof
#24Methods of preparing 1′-cyano nucleosides
#25CYCLIC DINUCLEOTIDES AS STING AGONISTS
#26CD73 inhibitors
#27Ectonucleotidase inhibitors and methods of use thereof
#28CD73 INHIBITORS
#29NEW EQUATORIALLY MODIFIED POLYMER LINKED MULTIMERS OF GUANSINE-3', 5'-CYCLIC MONOPHOSPHATES
#30Galactoside inhibitor of galectins
#31SMALL-MOLECULE COMPOUND HAVING A2A ADENOSINE RECEPTOR ANTAGONISM
#32CD73 INHIBITORS
#33CD73 inhibitors
#34HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS
#35Solid forms of a CD73 inhibitor and the use thereof
#36Cyclic Di-Nucleotide Compounds as STING Agonists
#37Cyclic Di-Nucleotide Compounds as STING Agonists
#38Galactoside inhibitor of galectins
#39Phosphorous protecting groups and methods of preparation and use thereof
#40PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF 1`-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS
#41Crystalline forms of a CD73 inhibitor and uses thereof
#42Modulators of 5′-nucleotidase, ecto and the use thereof
#43ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK
#44Substituted Alloxazine Nucleosides and Nucleotides, and Methods of Making Same
#45Methods of preparing 1′-cyano nucleosides
#46DIHETEROCYCLIC TRIAZINONE NUCLEOSIDE ANALOGS AND THEIR USE FOR MEDICATION
#47Cyclic dinucleotides as sting agonists
#482′-substituted carba-nucleoside analogs for antiviral treatment
#49CD73 inhibitors
#50CD73 inhibitors and pharmaceutical uses thereof
#51CD73 inhibitors
#52CD73 inhibitors
#53Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
#54Inhibitors of E1 activating enzymes
#55CD73 inhibitors
#56Nucleoside analogues for the treatment of parasitic infections
#57Modulators of 5′-nucleotidase, ecto and the use thereof
#58Substituted pyridopyrrolopyrimidine ribonucleosides for therapeutic uses
#59Salt of pyranose-substituted heterocyclic compound, preparation method therefor and use thereof
#60CD73 inhibitors
#61Inhibitors of adenosine 5′-nucleotidase
#62Photoresponsive nucleotide analog capable of photocrosslinking in visible light region
#63NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
#64Inhibitors of CD73-mediated immunosuppression
#65Ectonucleotidase inhibitors and methods of use thereof
#66Nucleoside and nucleotide analogues bearing a quaternary all-carbon stereogenic center at the 2′ position and methods of use as a cardioprotective agent
#67Nucleoside analogues and methods of use thereof
#68Modulators of 5′-nucleotidase, ecto and the use thereof
#69Equatorially modified polymer linked multimers of guanosine-3′, 5′-cyclic monophosphates
#70ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF
#71Phosphorous protecting groups and methods of preparation and use thereof
#72DEUTERATED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
#73Substituted heteropentadieno-pyrrolopyrimidine ribonucleosides for therapeutic use
#74Cyclic dinucleotides as anticancer agents
#752′-substituted carba-nucleoside analogs for antiviral treatment
#76Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs
#77NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
#78Cyclic di-nucleotide compounds as STING agonists
#79Cyclic di-nucleotide compounds as sting agonists
#80METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUSES AND PESTIVIRUSES
#81Cyclic di-nucleotide compounds as STING agonists
#82METHOD FOR THE SYNTHESIS OF PENTOSTATIN
#83SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES
#84MUTAGENIC NUCLEOSIDE ANALOGS AND USES THEREOF
#85Analogs of adenosine monophosphate (AMP) as inhibitors of ubiquitin-like modifier-activating enzyme ATG7
#86Modulators of 5′-nucleotidase, ecto and the use thereof
#87Alternative nucleic acid molecules and uses thereof
#88METHOD OF PREPARATION OF ANTIVIRAL COMPOUNDS AND USEFUL INTERMEDIATES THEREOF
#892'- SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT
#90Cyclic di-nucleotide compounds as sting agonists
#91POLYNUCLEOTIDE MOLECULES AND USES THEREOF
#92Substituted nucleoside derivatives useful as anticancer agents
#934'-AZIDO SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF EBOLA VIRUS RNA REPLICATION
#94Mutagenic nucleoside analogs and uses thereof
#95Novel Ticagrelor Co-Crystal
#96NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
#97NNA-DNA adducts as biomarkers for detecting exposure to thirdhand smoke
#98Effective treatment of esophageal adenocarcinoma using triciribine and related compounds
#99Phosphorous protecting groups and methods of preparation and use thereof
#100Universal methylation profiling methods
#101Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds
#102Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
#103Purine nucleoside analogues for treating flaviviridae including hepatitis C
#104Method to improve antiviral activity of nucleotide analogue drugs
#1052′-chloro nucleoside analogs for HCV infection
#106Anti-viral pyrimidine nucleoside analogues
#1071'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT
#108Macrocyclic nucleoside phosphoramidate derivatives
#109Methods and compositions for treating flaviviruses and pestiviruses
#1103,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
#1112′-substituted carba-nucleoside analogs for antiviral treatment
#112Photocleavable labeled nucleotides and nucleosides and methods for their use in DNA sequencing
#113Inhibitors of Akt/PKB with anti-tumor activity
#1141′-substituted carba-nucleoside analogs for antiviral treatment
#115Artificial fluorescent bases
#116Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds
#117Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
#1183,5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO[4,5-D]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF
#119NUCLEOSIDE DERIVATIVES AS INHIBITORS OF VIRAL POLYMERASES
#1201′substituted carba-nucleoside analogs for antiviral treatment
#1213′OH-unblocked, nucleotides and nucleosides base modified with labels and photocleavable, terminating groups and methods for their use in DNA sequencing
#1223,5-disubstituted and 3,5,7-trisubstituted-3-oxazolo and 3-thiazolo[4,5-]pyrimidin-2-one compounds and prodrugs thereof
#123Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
#1242'-F MODIFIED RNA INTERFERENCE AGENTS
#125Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs
#126UNIVERSAL METHYLATION PROFILING METHODS
#127INHIBITORS OF E1 ACTIVATING ENZYMES
#128Glycosylated indolocarbazoles, method for obtaining same and uses thereof
#129NON-NATURAL RIBONUCLEOTIDES, AND METHODS OF USE THEREOF
#130Crystalline forms of a pharmaceutical compound
#131Nucleoside analogues with quaternary carbon stereogenic centers and methods of use
#132Anti-viral pyrimidine nucleoside analogues
#133NOVEL TRICYCLIC NUCLEOSIDES OR NUCLEOTIDES AS THERAPEUTIC AGENTS
#134Bicyclic nucleosides and nucleotides as therapeutic agents
#135METHODS FOR INCREASING IN VIVO EFFICACY OF OLIGONUCLEOTIDES AND INHIBITING INFLAMMATION IN MAMMALS
#136Nucleoside analogs for treatment of viral infections
#137Nucleoside derivatives as inhibitors of viral polymerases
#138ORGANIC COMPOUNDS
#139Antiviral nucleosides
#140Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds
#141Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
#142PRODRUGS OF TRICIRIBINE AND TRICIRIBINE PHOSPHATE
#1431′-substituted carba-nucleoside analogs for antiviral treatment
#144Antiviral nucleoside analogs
#145Carba-nucleoside analogs for antiviral treatment
#146Nucleosides with antiviral and anticancer activity
#147Tricyclic-Nucleoside Compounds for Treating Viral Infections
#148Fused pyrimidines as inhibitors of nucleoside phosphorylases and nucleosidases
#149Analogues of coformycin and their use for treating protozoan parasite infections
#150Tricyclic-Nucleoside Prodrugs for Treating Viral Infections
#151Purine nucleoside analogues for treating including hepatitis C
#1523′-OH unblocked nucleotides and nucleosides, base modified with labels and photocleavable, terminating groups and methods for their use in DNA sequencing
#153AMINO TRICYCLIC-NUCLEOSIDE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE
#154Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
#155TRICYCLIC-NUCLEOSIDE COMPOUNDS FOR TREATING VIRAL INFECTIONS
#156Inhibitors of AKT/PKB with anti-tumor activity
#157Bicyclic Nucleosides and Nucleotides as Therapeutic Agents
#158Nucleoside derivatives for treating hepatitis C virus infection
#159Tricyclic nucleosides or nucleotides as therapeutic agents
#1603′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing
#161Mutagenic Heterocycles
#162MUTAGENIC HETEROCYCLES
#163Process for producing indolopyrrolocarbazole derivative
#164Labeling reagent
#165Crystalline forms of a pharmaceutical compound
#166Tricyclic nucleosides or nucleotides as therapeutic agents
#167Methods and compositions for treating flaviviruses and pestiviruses
#168Tricyclic-nucleoside compounds for treating viral infections
#169Process for preparing pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
#170Labeling reagent
#171Tricyclic-nucleoside prodrugs for treating viral infections
#172Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymes
#173Methods and compositions for treating flaviviruses and pestiviruses
#1743,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
#1755h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
#176Modified oligonucleotides for mismatch discrimination
#177Anti-viral 7-deaza L-nucleosides
#178Tleveling compositions
#179Process for producing indolopyrrolocarbazole derivative
#180Benzodeazaadenine derivative base and electronic material containing the same
#181TM leveling methods
#182Purine nucleoside analogues for treating Flaviviridae including hepatitis C
#183Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
#184Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
#185Compositions for treatment of inflammation
#186Information storage with rectified dna
#187Nucleoside heterocycle that binds to both thymidine and cytidine